SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Pharmacy Practice
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Singh, A. C.
Right arrow Articles by Honeywell, M. S.
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Addressing Nonadherence in the Schizophrenic Population

Angela C. Singh, PharmD

Florida A&M University College of Pharmacy and Pharmaceutical Sciences, 1415 S. Martin Luther King Blvd, Tallahassee, FL 32307, Angela.Singh{at}famu.edu

Angela J. Massey, PharmD, BCPP

Florida A&M University College of Pharmacy and Pharmaceutical Sciences

Michael D. Thompson, PharmD, BCNP

Florida A&M University College of Pharmacy and Pharmaceutical Sciences, Tallahassee

Leonard R. Rappa, PharmD, BCPP

Florida A&M University College of Pharmacy and Pharmaceutical Sciences, Miami

Marlon S. Honeywell, PharmD

Florida A&M University College of Pharmacy and Pharmaceutical Sciences, Tallahassee

Nonadherence within the schizophrenic population is a challenge for both the patient and the clinician. This problem not only causes an increase in health care use and cost but also places the patient at risk of relapse and dissatisfaction with medical care. Nonadherence is influenced by several factors including disease, treatment, and psychological and social factors. All of these factors must be addressed if the clinician hopes to reduce nonadherence within this patient population. This article will attempt to identify factors that contribute to nonadherence and review strategies that can be implemented to address each of these factors.

Key Words: Nonadherence • schizophrenia • addressing • strategies • treatment • psychosocial • disease • factors.

Journal of Pharmacy Practice, Vol. 19, No. 6, 361-368 (2006)
DOI: 10.1177/0897190007300726
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement